In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boehringer Ingelheim And Zhejiang Hisoar Pharmaceutical Sign Production Alliance

This article was originally published in PharmAsia News

Executive Summary

Boehringer Ingelheim and Zhejiang Hisoar Pharmaceutical have signed a strategic production alliance. Under the agreement, Hisoar will invest in a specialized workshop at its new plant in Chuannan and is scheduled to manufacture contract products for BI from 2009. The latter on its part will provide expertise and technology support for Hisoar. Listed on the Shenzhen bourse in 2006, Hisoar specializes in producing and selling pharmaceutical chemicals, active pharmaceutical ingredients and generic drugs. It has established GMP and EHS systems according to international standards. The firm said that the BI collaboration will boost its market position and influence, as well as give it a major leg-up toward globalization



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts